Pridinol
Clinical data | |
---|---|
Trade names | Myopridin |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth, parenteral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.007.390 |
Chemical and physical data | |
Formula | C20H25NO |
Molar mass | 295.426 g·mol−1 |
| |
(what is this?) (verify) |
Pridinol, sold under the brand name Myopridin, is a muscle relaxant that is used as an antiparkinsonian and anticholinergic drug.[1] It has also been evaluated for the treatment of muscle related pain.[2]
It was approved for medical use in the UK in May 2020.[3]
References
- ^ Budavari S, ed. (1989). The Merck index an encyclopedia of chemicals, drugs, and biologicals (11th ed., 2nd print. ed.). Rahway, NJ: Merck. p. 7747. ISBN 091191028X.
- ^ Überall MA, Essner U, Müller-Schwefe GH (July 2022). "Efficacy and safety/tolerability of pridinol: a meta-analysis of double-blind, randomized, placebo-controlled trials in adult patients with muscle pain". Current Medical Research and Opinion. 38 (7): 1141–1151. doi:10.1080/03007995.2022.2072089. PMID 35502575.
- ^ "Pridinol". SPS - Specialist Pharmacy Service. 10 August 2020. Retrieved 21 August 2020.
External links
- "Pridinol". Drug Information Portal. U.S. National Library of Medicine.